976 related articles for article (PubMed ID: 18179845)
1. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
2. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
[TBL] [Abstract][Full Text] [Related]
5. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
[TBL] [Abstract][Full Text] [Related]
6. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.
Grünblatt E; Zehetmayer S; Bartl J; Löffler C; Wichart I; Rainer MK; Jungwirth S; Bauer P; Danielczyk W; Tragl KH; Riederer P; Fischer P
J Psychiatr Res; 2009 Jan; 43(3):298-308. PubMed ID: 18603262
[TBL] [Abstract][Full Text] [Related]
7. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
9. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
Hwang JP; Tsai SJ; Hong CJ; Yang CH; Lirng JF; Yang YM
Neurobiol Aging; 2006 Dec; 27(12):1834-7. PubMed ID: 16343697
[TBL] [Abstract][Full Text] [Related]
10. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A
Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
[TBL] [Abstract][Full Text] [Related]
12. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease.
Fehér A; Juhász A; Rimanóczy A; Kálmán J; Janka Z
Alzheimer Dis Assoc Disord; 2009; 23(3):224-8. PubMed ID: 19812463
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
15. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.
Aguilera M; Arias B; Wichers M; Barrantes-Vidal N; Moya J; Villa H; van Os J; Ibáñez MI; Ruipérez MA; Ortet G; Fañanás L
Psychol Med; 2009 Sep; 39(9):1425-32. PubMed ID: 19215635
[TBL] [Abstract][Full Text] [Related]
16. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.
Montag C; Weber B; Fliessbach K; Elger C; Reuter M
Psychol Med; 2009 Nov; 39(11):1831-9. PubMed ID: 19335934
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset.
Tsai SJ; Hong CJ; Liu HC; Liu TY; Hsu LE; Lin CH
Neuropsychobiology; 2004; 49(1):10-2. PubMed ID: 14730194
[TBL] [Abstract][Full Text] [Related]
20. Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan.
Akatsu H; Yamagata HD; Kawamata J; Kamino K; Takeda M; Yamamoto T; Miki T; Tooyama I; Shimohama S; Kosaka K
Dement Geriatr Cogn Disord; 2006; 22(3):216-22. PubMed ID: 16899999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]